JAN vs WELL vs AHR Stock Comparison

Janus Living, Welltower and American Healthcare REIT Prices as of Nov 13, 2026 Peers: Industry group
JAN Janus Living, Inc.
$31.82 +9.8% 1M
Market cap
$7.24B
P/E
–
Revenue (TTM)
$835.56M
Div. yield
–
Healthcare REITs Real Estate
WELL Welltower Inc.
$244.49 +5.3% 1M +28.0% 1Y
Market cap
$177.69B
P/E
106.6x
Revenue (TTM)
$13.79B
Div. yield
–
Healthcare REITs Real Estate
8 wins

Head to Head

10 decided of 12

Welltower leads on 8 of the 12 questions below (Welltower 8, American Healthcare REIT 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionJANWELLAHRLeader
Larger companyMarket capitalisation $7.24B $177.69B $12.57B WELL
Cheaper on earningsLower P/E, profitable companies only -3,349x 106.6x 130.5x WELL
Cheaper on forward earningsLower price / next fiscal year consensus EPS 318.2x 83.2x 91.7x WELL
Faster revenue growthRevenue growth, trailing twelve months — +39.2% +21.5% WELL
More profitableNet margin, trailing twelve months -0.3% 12.1% 3.6% WELL
Better return on capitalReturn on invested capital -21.2% 0.7% -31.7% WELL
Less leveragedLower net debt / EBITDA — 4.2x -0.7x AHR
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% –
Better 1-year returnPrice return, last 12 months — +28.0% +19.8% WELL
Better 5-year returnAnnualised price return, 5 years — +23.4%/yr — –
Less volatileAnnualised volatility, 1 year 28.9% 23.6% 26.6% WELL
Higher overall scoreMean of the five percentile scores vs peers 25/100 41/100 44/100 AHR

Percentile Scorecard

JANWELLAHR

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisJANWELLAHR
Valuation 1 #147 of 149 2 #146 of 149 5 #141 of 149
Growth – 83 #26 of 147 86 #22 of 147
Profitability 26 #107 of 144 27 #105 of 144 25 #109 of 144
Financial Health 72 #43 of 149 89 #18 of 149 84 #25 of 149
Shareholder Returns 2 #136 of 139 5 #132 of 139 22 #109 of 139
Overall 25 41 44
  • JAN ranked among 150 companies in Property REITs
  • WELL ranked among 150 companies in Property REITs
  • AHR ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodJANWELLAHRSPY
1 month +9.8%+5.3%+10.2% -2.0%
3 months +3.9%+3.8%+6.4% -2.8%
6 months +19.3%+14.4%+17.1% +2.0%
Year to date —+31.7%+22.8% +10.6%
1 year —+28.0%+19.8% +12.2%
3 years —+181.2%— +68.1%
3 years, per year —+41.2%— +18.9%
5 years —+185.8%— +61.4%
5 years, per year —+23.4%— +10.1%
10 years —+297.4%— +248.5%
10 years, per year —+14.8%— +13.3%

Risk

MeasureJANWELLAHRSPY
Volatility, 1Y 28.9%23.6%26.6% 13.6%
Downside volatility, 1Y 26.9%25.2%27.3% 13.9%
Beta vs S&P 500, 1Y -0.01-0.010.05 1.00
Return / volatility, 1Y —1.180.74 0.90
Max drawdown, 5Y -13.8%-41.6%-14.5% -25.4%
From 52-week high -3.2%-3.1%-2.7% -3.2%
52-week high $32.88$252.22$59.40 $779.14
52-week low $22.88$181.96$45.69 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleJANWELLAHR
P/E now vs peer median -3,327xmedian 26.1x 106.3xmedian 26.1x 130.1xmedian 26.1x
P/S now vs peer median 8.9xmedian 4.3x 13.0xmedian 4.3x 5.0xmedian 4.3x
EV/EBITDA now vs peer median -10.9xmedian 14.5x 60.7xmedian 14.5x -9.3xmedian 14.5x
P/FCF now vs peer median -3.5xmedian 21.4x -10.0xmedian 21.4x -20.2xmedian 21.4x
P/B now vs peer median 1.8xmedian 1.2x 3.6xmedian 1.2x 2.4xmedian 1.2x
PEG now vs peer median —median 1.75 1.60median 1.75 4.02median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsJANWELLAHR
Revenue $835.56M $13.79B $2.67B
Gross profit – $5.41B $589.22M
Operating income -$871.49M $504.64M -$1.92B
Net income $38.54M $1.75B $97.45M
Free cash flow -$2.15B -$17.96B -$662.56M
EPS (diluted) $-0.01 $2.21 $0.44
Cash & equivalents $338.06M $2.27B $258.67M
Total debt – $15.73B $1.36B
Shares (diluted) 225.97M 754.90M 217.71M
Enterprise value $4.37B $163.71B $11.81B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricJANWELLAHR
P/E -3,327x 106.3x 130.1x
P/FCF -3.5x -10.0x -20.2x
P/Operating cash flow 30.0x 53.8x 31.8x
P/S 8.9x 13.0x 5.0x
P/B 1.8x 3.6x 2.4x
P/Tangible book 2.0x 3.9x 2.6x
EV/EBITDA -10.9x 60.7x -9.3x
EV/EBIT -8.2x 382.1x -7.6x
EV/Revenue 8.5x 14.0x 5.4x
EV/FCF -3.3x -10.7x -21.9x
EV/Operating cash flow 28.7x 57.9x 34.4x
PEG (3Y EPS CAGR) – 1.60 4.02

Growth

14 metrics
MetricJANWELLAHR
Revenue growth (1Y) – 39.2% 21.5%
Revenue CAGR (3Y) – 29.1% 16.8%
Gross profit growth (1Y) – 37.1% 29.5%
Gross profit CAGR (3Y) – 28.4% 43.5%
Operating income growth (1Y) – -66.4% -21.6%
Operating income CAGR (3Y) – -16.4% -6.8%
Net income growth (1Y) – 80.6% 255.0%
Net income CAGR (3Y) – 86.0% 44.8%
EPS growth (1Y) – 57.6% 175.6%
EPS CAGR (3Y) – 66.2% 32.4%
Operating cash flow growth (1Y) – 19.5% 41.2%
Operating cash flow CAGR (3Y) – 30.9% 57.9%
Free cash flow growth (1Y) – -282.6% -1,027%
Free cash flow CAGR (3Y) – -162.3% -114.2%

Profitability

14 metrics
MetricJANWELLAHR
Gross margin – 39.2% 22.1%
EBITDA margin -78.3% 23.0% -58.3%
Operating margin -104.3% 3.7% -71.8%
Pretax margin 4.7% -1.9% 3.6%
Net margin -0.3% 12.1% 3.6%
FCF margin -257.6% -130.2% -24.8%
Operating cash flow margin 29.7% 24.1% 15.8%
Return on equity 1.0% 3.6% 2.1%
Return on assets 0.8% 2.4% 1.5%
Return on invested capital -21.2% 0.7% -31.7%
Return on capital employed – – –
Asset turnover 0.2x 0.2x 0.4x
Cash conversion (OCF / net income) 6.4x 1.9x 4.3x
Stock comp / revenue 0.1% 11.4% 0.9%

Financial Health

11 metrics
MetricJANWELLAHR
Debt / assets – 21.3% 17.9%
Debt / equity – 0.3x 0.2x
Net debt / EBITDA – 4.2x -0.7x
Debt / FCF – -0.9x -2.1x
Liabilities / assets 21.0% 32.7% 26.6%
Equity / assets 79.0% 67.3% 73.4%
Interest coverage -407.8x 0.7x -25.6x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricJANWELLAHR
Dividend yield 1.3% 1.3% 1.7%
Net buyback yield -11.2% -5.3% -22.2%
Shareholder yield -9.9% -4.0% -20.5%
Payout ratio (earnings) – – 190.9%
Payout ratio (FCF) – – -28.1%
Dividend growth (1Y) – – 17.0%
Dividend CAGR (3Y) – – 35.1%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusJANWELLAHR
Forward P/E 318.2xFY2026 83.2xFY2026 91.7xFY2026
EPS, next fiscal year $0.10FY2026 $2.94FY2026 $0.63FY2026
EPS growth, next FY +150.0%FY2026 +111.5%FY2026 +50.0%FY2026
EPS growth, the year after -10.0% +18.0% +36.5%
Revenue, next fiscal year $885.94MFY2026 $13.66BFY2026 $2.65BFY2026
Revenue growth, next FY +27.8%FY2026 +26.0%FY2026 +17.1%FY2026
Revenue growth, the year after +42.3% +18.6% +29.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersJANWELLAHR
Held by institutions 38.1% 98.3% 100.0%
Institutions holding 162 1,587 573
Change in shares held, QoQ +56.8% +5.6% +19.9%
Institutions buying 137 879 335
Institutions selling 19 475 165
Buyers to sellers 7.21 1.85 2.03

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

JANWELLAHR
JAN 1.00 0.50 0.60
WELL 0.50 1.00 0.76
AHR 0.60 0.76 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, JAN, WELL and AHR?

Welltower (WELL) is the largest by market capitalisation: Janus Living (JAN) $7.24B, Welltower (WELL) $177.69B, American Healthcare REIT (AHR) $12.57B.

Which stock is cheaper, JAN, WELL and AHR?

Welltower (WELL) trades on the lowest price-to-earnings ratio (Janus Living (JAN) -3,349x, Welltower (WELL) 106.6x, American Healthcare REIT (AHR) 130.5x). On next year's consensus earnings, Welltower (WELL) is cheapest (Janus Living (JAN) 318.2x, Welltower (WELL) 83.2x, American Healthcare REIT (AHR) 91.7x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Welltower (WELL) grew revenue fastest over the trailing twelve months: Welltower (WELL) +39.2%, American Healthcare REIT (AHR) +21.5%.

Which company is more profitable?

Welltower (WELL) has the highest net margin (Janus Living (JAN) -0.3%, Welltower (WELL) 12.1%, American Healthcare REIT (AHR) 3.6%). On return on invested capital, Welltower (WELL) leads (Janus Living (JAN) -21.2%, Welltower (WELL) 0.7%, American Healthcare REIT (AHR) -31.7%).

Which stock has performed better?

Over the past year Welltower (WELL) returned the most: Welltower (WELL) +28.0%, American Healthcare REIT (AHR) +19.8%. Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Janus Living (JAN) 0.00%, Welltower (WELL) 0.00%, American Healthcare REIT (AHR) 0.01%. Janus Living (JAN) and Welltower (WELL) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Welltower (WELL) has been the steadiest (Janus Living (JAN) 28.9%, Welltower (WELL) 23.6%, American Healthcare REIT (AHR) 26.6%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, JAN, WELL and AHR?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Welltower (WELL) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.